Correlations of van der Linden score and nutritional risk screening 2002 score with the prognosis of patients with spinal metastases

TONG Ling; ZHANG Rui; ZHANG Yurong; PENG Guolin; JIANG Xinting

doi:10.7619/jcmp.20232329

Journal of Clinical Medicine in Practice > 2023 > 27(21): 47-51. > DOI: 10.7619/jcmp.20232329

TONG Ling, ZHANG Rui, ZHANG Yurong, PENG Guolin, JIANG Xinting. Correlations of van der Linden score and nutritional risk screening 2002 score with the prognosis of patients with spinal metastases[J]. Journal of Clinical Medicine in Practice, 2023, 27(21): 47-51. DOI: 10.7619/jcmp.20232329

Citation:

PDF (879 KB)

Correlations of van der Linden score and nutritional risk screening 2002 score with the prognosis of patients with spinal metastases

Department of Orthopedics, the First Peoples′ Hospital of Yibin in Sichuan Province, Yibin, Sichuan, 644000

More Information

Received Date: July 23, 2023
Revised Date: September 06, 2023
Available Online: November 23, 2023

Graphical Abstract

Abstract

Abstract

Objective
To explore the correlations of van der Linden score and nutritional risk screening 2002 (NRS 2002) score with the prognosis of patients with spinal metastases.
Methods
From January 2010 to December 2020, the clinical data of 127 hospitalized patients with spinal metastases admitted to the First Peoples′ Hospital of Yibin were retrospectively analyzed, the follow-up was up to June 30, 2022. The Kaplan-Meier method was used to draw the survival curve, and Log-rank χ² test and Cox regression were used to analyze the correlations of van der Linden score and NRS 2002 score with the prognosis of patients with spinal metastases.
Results
The average follow-up time was 11.7 months, and the median survival time was 10 months. The mortality rate during the follow-up period was 76.38%, and the 6-month and 12-month survival rates were 69.29% and 27.56%, respectively. The survival time of patients with van der Linden scores of 0 to 3 points, 4 to 5 points, and 6 points was (7.50±2.86) months, (15.45±4.49) months, and (19.00±6.40) months, with the 12-month survival rates of 3.75%, 65.00%, and 85.71%, respectively. The 12-month survival rates of patients with NRS 2002 scores < 3 points and ≥3 points were 34.21% and 17.65%, respectively. Cox regression analysis showed that van der Linden score and NRS 2002 score were influencing factors for the prognosis of spinal metastases. Taking HR(95%CI) of van der Linden score at 6 points as the reference, the HR (95%CI) of van der Linden scores at 0 to 3 points and 4 to 5 points were 6.915 (2.048 to 23.363) and 1.715 (1.068 to 2.757), respectively. The HR(95%CI) of NRS 2002 scores ≥3 was 1.838 (1.186 to 2.850) taking NRS 2002 < 3 score as the reference.
Conclusion
The overall prognosis of patients with spinal metastases is poor. The van der Linden score and NRS 2002 score are related with the prognosis of patients.
- spinal metastases,
- van der Linden score,
- nutritional risk screening 2002,
- prognosis

FullText(HTML)

References (19)

References

[1]	JELGERSMA C, VAJKOCZY P. How to target spinal metastasis in experimental research: an overview of currently used experimental mouse models and future prospects[J]. Int J Mol Sci, 2021, 22(11): 5420. doi: 10.3390/ijms22115420
[2]	GLICKSMAN R M, TJONG M C, NEVES-JUNIOR W F P, et al. Stereotactic ablative radiotherapy for the management of spinal metastases: a review[J]. JAMA Oncol, 2020, 6(4): 567-577. doi: 10.1001/jamaoncol.2019.5351
[3]	ORENDAY-BARRAZA J M, CAVAGNARO M J, AVILA M J, et al. 10-year trends in the surgical management of patients with spinal metastases: a scoping review[J]. World Neurosurg, 2022, 157: 170-186. doi: 10.1016/j.wneu.2021.10.086
[4]	TARABAY B, GENNARI A, TRUONG V T, et al. Which scoring system is the most accurate for assessing survival prognosis in patients undergoing surgery for spinal metastases from lung cancer?A single-center experience[J]. World Neurosurg, 2022, 168: e408-e417. doi: 10.1016/j.wneu.2022.10.061
[5]	TABOUREL G, TERRIER L M, DUBORY A, et al. Are spine metastasis survival scoring systems outdated and do they underestimate life expectancy Caution in surgical recommendation guidance[J]. J Neurosurg Spine, 2021, 35(4): 527-534. doi: 10.3171/2020.12.SPINE201741
[6]	VAN DER LINDEN Y M, DIJKSTRA S P, VONK E J, et al. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy[J]. Cancer, 2005, 103(2): 320-328. doi: 10.1002/cncr.20756
[7]	CHEN B, ZENG Y, LIU B, et al. Risk factors, prognostic factors, and nomograms for distant metastasis in patients with newly diagnosed osteosarcoma: a population-based study[J]. Front Endocrinol (Lausanne), 2021, 12: 672024. doi: 10.3389/fendo.2021.672024
[8]	CASSIDY J T, BAKER J F, LENEHAN B. The role of prognostic scoring systems in assessing surgical candidacy for patients with vertebral metastasis: a narrative review[J]. Glob Spine J, 2018, 8(6): 638-651. doi: 10.1177/2192568217750125
[9]	FANG K H, CHANG S W, LEE Y C, et al. Preoperative prognostic nutritional index predicts prognosis of patients with oral cavity cancer[J]. Oral Dis, 2022, 28(7): 1816-1830. doi: 10.1111/odi.13840
[10]	ZHANG Z H, WAN Z, ZHU Y, et al. Prevalence of malnutrition comparing NRS2002, MUST, and PG-SGA with the GLIM criteria in adults with cancer: a multi-center study[J]. Nutrition, 2021, 83: 111072. doi: 10.1016/j.nut.2020.111072
[11]	CUI Y P, LEI M X, PAN Y X, et al. Scoring algorithms for predicting survival prognosis in patients with metastatic spinal disease: the current status and future directions[J]. Clin Spine Surg, 2020, 33(8): 296-306. doi: 10.1097/BSD.0000000000001031
[12]	LIU Y J, LI L, JIANG D J, et al. A novel nomogram for survival prediction of patients with spinal metastasis from prostate cancer[J]. Spine (Phila Pa 1976), 2021, 46(6): E364-E373. doi: 10.1097/BRS.0000000000003888
[13]	LUN D X, CHEN N W, FENG J T, et al. Visceral metastasis: a prognostic factor of survival in patients with spinal metastases[J]. Orthop Surg, 2020, 12(2): 552-560. doi: 10.1111/os.12657
[14]	EHRESMAN J, AHMED A K, SCHILLING A, et al. Preoperative nutrition consults associated with decreased postoperative complication rate and decreased length of hospital stay after spine metastasis surgery[J]. World Neurosurg, 2020, 133: e173-e179. doi: 10.1016/j.wneu.2019.08.197
[15]	崔嘉明. 比较八种评分系统对脊柱转移瘤预后评估价值的研究[D]. 广州: 暨南大学, 2020.
[16]	HERSBERGER L, BARGETZI L, BARGETZI A, et al. Nutritional risk screening (NRS 2002) is a strong and modifiable predictor risk score for short-term and long-term clinical outcomes: secondary analysis of a prospective randomised trial[J]. Clin Nutr, 2020, 39(9): 2720-2729. doi: 10.1016/j.clnu.2019.11.041
[17]	ĪLERI Ī, ÖZSÜREKCI C, HALIL M G, et al. NRS-2002 and mNUTRIC score: could we predict mortality of hematological malignancy patients in the ICU[J]. Nutr Clin Pract, 2022, 37(5): 1199-1205. doi: 10.1002/ncp.10783
[18]	ⅡNUMA M, AKAZAWA T, TORⅡ Y, et al. Optimization of the revised tokuhashi scoring system: new prognostic criteria for metastatic spinal tumor in surgical cases[J]. Spine Surg Relat Res, 2021, 5(2): 81-85. doi: 10.22603/ssrr.2020-0102
[19]	JOANNE M, VAN DER VELDEN, et al. Spinal stereotactic radiotherapy for painful spinal metastasis[J]. Lancet Oncol, 2021, 22(7): 901-903. doi: 10.1016/S1470-2045(21)00268-0

Cited By

Get Citation

PDF

XML

Article views (79) PDF downloads (4)

Turn off MathJax

Article Contents

Abstract

References

Correlations of van der Linden score and nutritional risk screening 2002 score with the prognosis of patients with spinal metastases

Abstract

References

Catalog

Export File

Citation

Format

Content